Scheinberg DA - Search Results

1

Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.

Dao T, Pankov D, Scott A, Korontsvit T, Zakhaleva V, Xu Y, Xiang J, Yan S, de Morais Guerreiro MD, Veomett N, Dubrovsky L, Curcio M, Doubrovina E, Ponomarev V, Liu C, O'Reilly RJ, Scheinberg DA. Dao T, et al. Among authors: scheinberg da. Nat Biotechnol. 2015 Oct;33(10):1079-86. doi: 10.1038/nbt.3349. Epub 2015 Sep 21. Nat Biotechnol. 2015. PMID: 26389576 Free PMC article.

2

Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase N.

Xu Y, Wellner D, Scheinberg DA. Xu Y, et al. Among authors: scheinberg da. Biochem Biophys Res Commun. 1995 Mar 17;208(2):664-74. doi: 10.1006/bbrc.1995.1390. Biochem Biophys Res Commun. 1995. PMID: 7535053 Free article.

3

Impact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivity.

Nikula TK, Bocchia M, Curcio MJ, Sgouros G, Ma Y, Finn RD, Scheinberg DA. Nikula TK, et al. Among authors: scheinberg da. Mol Immunol. 1995 Aug;32(12):865-72. doi: 10.1016/0161-5890(95)00052-g. Mol Immunol. 1995. PMID: 7565813

4

A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies.

Nikula TK, Curcio MJ, Brechbiel MW, Gansow OA, Finn RD, Scheinberg DA. Nikula TK, et al. Among authors: scheinberg da. Nucl Med Biol. 1995 Apr;22(3):387-90. doi: 10.1016/0969-8051(94)00126-5. Nucl Med Biol. 1995. PMID: 7627155

5

Specific human cellular immunity to bcr-abl oncogene-derived peptides.

Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA. Bocchia M, et al. Among authors: scheinberg da. Blood. 1996 May 1;87(9):3587-92. Blood. 1996. PMID: 8611681 Free article.

6

Antileukemic activity of recombinant humanized M195-gelonin immunotoxin in nude mice.

Xu Y, Xu Q, Rosenblum MG, Scheinberg DA. Xu Y, et al. Among authors: scheinberg da. Leukemia. 1996 Feb;10(2):321-6. Leukemia. 1996. PMID: 8637241

7

The multidrug resistance phenotype confers immunological resistance.

Weisburg JH, Curcio M, Caron PC, Raghu G, Mechetner EB, Roepe PD, Scheinberg DA. Weisburg JH, et al. Among authors: scheinberg da. J Exp Med. 1996 Jun 1;183(6):2699-704. doi: 10.1084/jem.183.6.2699. J Exp Med. 1996. PMID: 8676093 Free PMC article.

8

Bone marrow dosimetry: regional variability of marrow-localizing antibody.

Sgouros G, Jureidini IM, Scott AM, Graham MC, Larson SM, Scheinberg DA. Sgouros G, et al. Among authors: scheinberg da. J Nucl Med. 1996 Apr;37(4):695-8. J Nucl Med. 1996. PMID: 8691269 Free article. Clinical Trial.

9

Cryptic and regulatory epitopes in CD13/aminopeptidase N.

Xu Y, Wellner D, Scheinberg DA. Xu Y, et al. Among authors: scheinberg da. Exp Hematol. 1997 Jun;25(6):521-9. Exp Hematol. 1997. PMID: 9197331

10

Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells.

Bocchia M, Xu Q, Wesley U, Xu Y, Korontsvit T, Loganzo F, Albino AP, Scheinberg DA. Bocchia M, et al. Among authors: scheinberg da. Leuk Res. 1997 May;21(5):439-47. doi: 10.1016/s0145-2126(96)00085-9. Leuk Res. 1997. PMID: 9225073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page